MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Brain Metastases
Related studies linked through entity extraction aliases.
FSRT in Breast Cancer Patients With Brain Metastases
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Determine the Efficiency For Brain Metastasis NSCLC Patients Treated With Icotinib Alone or Combined With Radiation Therapy
- Status
- UNKNOWN
- Phase
- PHASE3
Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study
- Status
- TERMINATED
- Phase
- NA
Glucocorticoids, Immunotherapy and Radiosurgery for Brain Metastases
- Status
- COMPLETED
- Phase
- N/A
Study of Intraoperative Radiotherapy for Patients With Large Brain Metastases Treated With Neurosurgical Resection
- Status
- TERMINATED
- Phase
- NA
Efficacy of metfOrmin in PrevenTIng Glucocorticoid-induced Diabetes in Patients With Brain Metastases
- Status
- UNKNOWN
- Phase
- PHASE2
Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis
- Status
- TERMINATED
- Phase
- PHASE2
Re-craniotomy and Complications After Elective Neurosurgery
- Status
- COMPLETED
- Phase
- N/A
Encorafenib and Binimetinib Before Local Treatment in Patients With BRAF Mutant Melanoma Metastatic to the Brain
- Status
- COMPLETED
- Phase
- PHASE2
MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients with Triple Negative or HER2+ MBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
LIFE - Lung Cancer, Immunotherapy, Frailty, Effect
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE1
HFSRT With Concurrent TMZ for Large BMs
- Status
- UNKNOWN
- Phase
- PHASE3
Radiosurgery With or Without Whole Brain Radiation for Multiple Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Icotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation
- Status
- UNKNOWN
- Phase
- PHASE2
X-396(Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2